SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Medical - Healthcare >

InVivo Therapeutics Holdings Corp (NVIV)

Add NVIV Price Alert      Hide Sticky   Hide Intro
Moderator: TheHound
Search This Board: 
Last Post: 5/17/2017 8:35:40 AM - Followers: 189 - Board type: Free - Posts Today: 0

About InVivo Therapeutics 

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In 2011, the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. In 2015, the company’s investigational Neuro-Spinal Scaffold received the 2015 Becker’s Healthcare Spine Device Award. The publicly-traded company is headquartered in Cambridge, MA. For more details, visit

Ongoing Human Trials:
SEC Filings:
Recent News:
Share Structure:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NVIV News: InVivo Therapeutics Announces Presentation at Combined Canadian Spinal Cord & Ontario Spinal Cord Injury Research Network Mee... 05/09/2017 08:00:00 AM
NVIV News: InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Oregon Health and Science University 05/08/2017 08:00:00 AM
NVIV News: InVivo Therapeutics Provides Clinical Update and Reports 2017 First Quarter Financial Results 05/04/2017 04:36:00 PM
NVIV News: Quarterly Report (10-q) 05/04/2017 04:08:30 PM
NVIV News: Additional Proxy Soliciting Materials (definitive) (defa14a) 04/28/2017 06:06:49 AM
#5878   They don't need legitimate grounds. I'm not saying Buckboard 05/16/17 04:22:07 PM
#5877   On what grounds? Here is where you weather Pemmanuel 05/16/17 03:13:51 PM
#5876   Maybe all retail is out but you and attilathehunt 05/16/17 03:02:14 PM
#5875   How long before you think the lawyers start Buckboard 05/16/17 02:52:40 PM
#5874   Your scenario would happen if they bought in attilathehunt 05/15/17 08:50:36 AM
#5873   Of course the price would go down further DDobserver 05/15/17 05:29:35 AM
#5872   It sounds like they (management) are a bit attilathehunt 05/14/17 07:33:04 PM
#5871   Funny you should say that. I told the Buckboard 05/14/17 05:50:13 PM
#5870   Not here. I'm voting against everything for the attilathehunt 05/13/17 07:16:13 PM
#5869   Asked on other board and got no response Buckboard 05/12/17 03:48:02 PM
#5868   I always expected the 6 months post the Pemmanuel 05/12/17 09:19:19 AM
#5867   Unfortunately I agree with you. In light of attilathehunt 05/11/17 08:22:07 AM
#5866   Why would the federal government not approve it.....for DDobserver 05/11/17 02:09:16 AM
#5865   tell us, what person that gets that seriously ronala 05/10/17 02:40:28 PM
#5864   Market cap implies this is still trading near BioBull1 05/10/17 12:40:38 PM
#5863   Ddo, there are many biotechs and Pharmas within Pemmanuel 05/10/17 05:08:42 AM
#5862   Pemmanuel. The sticking point with INVIVO is that this DDobserver 05/09/17 11:18:22 PM
#5861   The Objective Performance Criteria is definitely defined by Pemmanuel 05/09/17 02:36:35 PM
#5860   I believe it was 25%. I don't doubt attilathehunt 05/06/17 05:28:01 PM
#5859   Save me some time and remind me what BioTekkie 05/06/17 05:18:35 PM
#5856   Or -- the price is so beaten down Pemmanuel 05/05/17 12:08:33 PM
#5853   Agreed. That is the most troubling. Sitting on attilathehunt 05/05/17 09:42:28 AM
#5852   Completely agree mastiff. This is the stuff that BioBull1 05/05/17 08:27:38 AM
#5851   MASSACRE....Schwab has the bid at $2.05. DDobserver 05/05/17 05:22:18 AM
#5850   I don't understand how they were aloud to mastiffsforlife 05/05/17 01:01:53 AM
#5849   Reversion of two patients disappointing but not fatal. The Lawman 05/04/17 09:40:18 PM
#5848   Unbelievable, well there goes that!! mastiffsforlife 05/04/17 08:51:07 PM
#5847   Same to you and I lost a ton Buckboard 05/04/17 07:53:56 PM
#5846   What a shame this turned out to be. I attilathehunt 05/04/17 07:39:50 PM
#5845   AH you can't get 2.75 and bid is Buckboard 05/04/17 07:35:29 PM
#5844   If I read the 10Q correctly...16 patients, 2 attilathehunt 05/04/17 04:39:49 PM
#5842   We will just have to agree to disagree DDobserver 04/28/17 09:52:23 AM
#5841   With regard to this stock I think most Pemmanuel 04/28/17 08:56:44 AM
#5840   Pemmuel no need to get upset for being DDobserver 04/28/17 02:16:58 AM
#5839   (I'm guessing brown lenses and a short frame) Pemmanuel 04/27/17 05:44:53 PM
#5838   Blatantly obvious the highest being in 2013 and Pemmanuel 04/27/17 03:15:33 PM
#5837   We must be looking at two different charts. DDobserver 04/27/17 09:56:23 AM
#5836   $NVIV almost always rises through May, June and Pemmanuel 04/26/17 08:50:12 AM
#5835   Shorts? No. Realist? Yes. BioBull1 04/25/17 08:50:44 AM
#5834   I already took into account they wouldn't take Pemmanuel 04/24/17 04:39:08 PM
#5832   Well.. think some of those things considered... now invest 04/24/17 01:15:44 PM
#5831   17 months of cash is a big misconception BioBull1 04/24/17 10:34:54 AM
#5830   Lots of old price targets and likely will BioBull1 04/24/17 10:27:22 AM
#5829   The company is currently at a 1.4MM per Pemmanuel 04/24/17 10:15:18 AM
#5828   I do not think they are fundamentally different. DDobserver 04/21/17 05:33:32 PM
#5826   Thanks for the clarity of 50mm shares authorized. DDobserver 04/21/17 12:31:35 PM
#5823   I added some a couple of days ago... now invest 04/20/17 02:07:12 PM
#5822   Regardless if it is a vote or a DDobserver 04/20/17 09:31:07 AM
#5821   That is patently false. The vote is a Pemmanuel 04/20/17 08:13:03 AM
#5820   I totally agree ronala. NVIV is entering a Pemmanuel 04/20/17 12:22:35 AM